Megatas-S 25 Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Megatas-S 25 Tablet ER
Uro-Duo 25 Extended-Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication alleviates urinary frequency, urgency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. Uro-Duo 25 ER may be taken with or without food, ideally at the same time daily. Discontinuing the medication prematurely without medical consultation could exacerbate symptoms; complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, upper respiratory inflammation (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or bothersome side effects to your doctor promptly. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Individuals with liver or kidney impairment should exercise caution, undergoing regular monitoring as directed by their doctor.
Primary Ingredients of Megatas-S 25 Tablet ER
No text provided to rephrase.
Uses of Megatas-S 25 Tablet ER
Bladder control problems
Major Benefits of Megatas-S 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Megatas-S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Megatas-S 25 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Megatas-S 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Megatas-S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Megatas-S 25 Tablet ER works:
Megatas-S 25 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary issues. Mirabegron, a beta-3 adrenergic agonist, eases bladder contractions by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through the relaxation of bladder musculature. This dual mechanism helps control frequent, urgent, and involuntary urination.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Megatas-S 25 Tablet ER. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Megatas-S 25 Tablet ER use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Megatas-S 25 Tablet ER with breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The impact of Megatas-S 25 Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Megatas-S 25 Tablet ER use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Megatas-S 25 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megatas-S 25 Tablet ER :
NA
Facts to Know About Megatas-S 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |
3,018 People bought this recently